Lessons learnt in conducting a clinical drug trial in children with Asperger Syndrome

John Mathai1, Angela Bourne, Noel Cranswick

  • 1Child and Adolescent Psychiatrist, Royal Children's Hospital, Mental Health Service, Parkville, Vic., Australia. john.mathai@rch.org.au

Insights

Recruiting children for clinical trials, especially those with Asperger Syndrome, presents significant challenges. Despite difficulties, an appropriate setting and experienced staff facilitated this drug trial.

Area of Science:

  • Pediatric clinical pharmacology
  • Autism Spectrum Disorder research

Background:

  • Clinical drug trials in children with Asperger Syndrome are complex.
  • Understanding challenges in pediatric trial recruitment is crucial.

Purpose of the Study:

  • To detail the experience of a clinical drug trial in pediatric patients with Asperger Syndrome.
  • To identify challenges and lessons learned during the trial process.

Main Methods:

  • Descriptive analysis of a clinical drug trial conducted in children with Asperger Syndrome.
  • Documentation of recruitment experiences and operational facilitators.

Main Results:

  • The primary challenge was patient recruitment, failing to meet the target of 60 children.
  • Successful trial conduct was supported by a suitable research environment and skilled clinical pharmacology personnel.

Conclusions:

  • Pediatric patient recruitment is a critical barrier in clinical trial progression.
  • The study highlights the importance of infrastructure and expertise in conducting pediatric drug trials.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...